No Prescription |
 |
 | ||
|
Loraclear Claritin |
|
| ||
No Prescription » Prescription Drugs 10 » Loraclear Claritin This medication is an antihistamine that treats symptoms such as itching runny nose watery eyes and sneezing from "hay fever" and other allergies. It is also used to relieve itching from hives.Loratadine does not prevent hives or prevent/treat a serious allergic reaction (e.g. anaphylaxis). Therefore if your doctor has prescribed epinephrine to treat allergic reactions always carry your epinephrine injector with you. Do not use loratadine in place of your epinephrine.If you are self-treating with this medication it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. (See also Precautions section.)Do not use this medication in children younger than 2 years unless directed by the doctor. Buy Loraclear Claritin and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Loraclear Claritin: Product Type: Prescription Drugs 10 Loraclear ( Claritin Generic Loratadine ) Product Origin: United Kingdom Loraclear (Claritin Generic Loratadine) Claritin Generic Loratadine 10mg Claritin Generic Loratadine Loraclear
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
